Skip to main content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

Embryonic and Adult Stem Cell Research - Addressing the Facts and the Issues: Home

This guide presents selected resources on background information about embryonic and adult stem cell research and related issues as well as perspectives from a variety of sources on the ethics this research.

Policy

The National Institutes of Health Guidelines for Human Stem Cell Research were published on July 7, 2009. This was in response to the March 9, 2009 Executive Order (EO) 13505 (see below), which changed the way National Institutes of Health (NIH) can support and conduct human stem cell research. The HHS Secretary, through the NIH Director, was required to review existing NIH and other widely-recognized guidelines on human stem cell research and issue new NIH guidance within 120 days of the date of the EO.

Guidelines Questions and Answers

Related Material

On March 9, 2009, President Barack Obama issued EO 13505, entitled Removing Barriers to Responsible Scientific Research Involving Human Stem Cells (108KB PDF).

In addition to requiring the above NIH guidelines, the EO also revoked:

See Also:

Page citation: NIH Stem Cell Information Home Page. In Stem Cell Information [World Wide Web site]. Bethesda, MD: National Institutes of Health, U.S. Department of Health and Human Services, 2016 [cited March 13, 2019] Available at < //stemcells.nih.gov/policy.htm> Note: Some of the links on the web page are broken.  These have been removed here.

Bone Marrow Cells

 

https://commons.wikimedia.org/wiki/File:Bone_marrow_WBC.JPG

Statistics, Data and a Timeline

NINDS

The National Institute of Neurological Disorders and Stroke, NINDS, operating as part of the National Institutes of Health, NINDS supports a diverse array of research on stem cells, from studies of the basic biology of stem cells in the developing and adult mammalian brain, to studies focusing on nervous system disorders such as ALS or spinal cord injury. Other examples of NINDS funded research include using iPS cells to derive dopamine-producing neurons that might alleviate symptoms in patients with Parkinson’s disease, and using ES cells to generate cerebral organoids to model Zika virus infection.

Estimates of Funding for Various Research, Condition, and Disease Categories, 2016-2019
(Click on right arrow below chart to see later years.)

Research/Disease Areas* FY 2016
(Actual)
FY 2017
(Actual)
FY 2018
Estimated
(Enacted)
FY 2019
Estimated
Stem Cell Research $1,516 $1,646 $1,748 $1,626

*Dollars in millions and rounded

Credit: National Institute of Neurological Disorders and Stroke

Stem Cell Research Organizations, Companies, etc.

 

 

Credit: Mikael Häggström.When using this image in external works, it may be cited as:Häggström, Mikael (2014). "Medical gallery of Mikael Häggström 2014" WikiJournal of Medicine 1 (2). DOI:10.15347/wjm/2014.008. ISSN 2002-4436. Public Domain.

Normal Stem Cells

   

This file is licensed under the Creative Commons Attributed-Share Alike 3.0 Unported license. 
Malymajo [CC BY-SA 3.0 (https://creativecommons.org/licenses/by-sa/3.0)]